ANAPLASTIC THYROID CANCER
Clinical trials for ANAPLASTIC THYROID CANCER explained in plain language.
Never miss a new study
Get alerted when new ANAPLASTIC THYROID CANCER trials appear
Sign up with your email to follow new studies for ANAPLASTIC THYROID CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo shows promise for rare thyroid cancer in early trial
Disease control Recruiting nowThis early-phase study tests whether giving two drugs (XL092 and cemiplimab) before surgery can help remove a rare and fast-growing thyroid cancer called anaplastic thyroid cancer. The study includes 12 adults whose cancer has a specific gene change (BRAF V600E). The main goals a…
Matched conditions: ANAPLASTIC THYROID CANCER
Phase: PHASE1 • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Disease control
Last updated May 14, 2026 12:04 UTC
-
New hope for deadly thyroid cancer? drug combo trial launches
Disease control Recruiting nowThis study tests a combination of two drugs, pembrolizumab and lenvatinib, in people with anaplastic thyroid cancer, a rare and fast-growing cancer. The goal is to see if the treatment shrinks tumors, slows cancer growth, and helps people live longer. About 20 adults who have not…
Matched conditions: ANAPLASTIC THYROID CANCER
Phase: PHASE2 • Sponsor: Saint Petersburg State University, Russia • Aim: Disease control
Last updated May 13, 2026 16:00 UTC